KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Bristol Myers Squibb (BMY) over the last 16 years, with Q4 2025 value amounting to 0.52.

  • Bristol Myers Squibb's Asset Utilization Ratio fell 56.86% to 0.52 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.52, marking a year-over-year decrease of 56.86%. This contributed to the annual value of 0.53 for FY2025, which is 257.82% up from last year.
  • Bristol Myers Squibb's Asset Utilization Ratio amounted to 0.52 in Q4 2025, which was down 56.86% from 0.5 recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Asset Utilization Ratio peaked at 0.52 during Q4 2024, and registered a low of 0.37 during Q1 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.48 (2023), whereas its average is 0.47.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 5499.91% in 2021, then crashed by 226.47% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Asset Utilization Ratio stood at 0.42 in 2021, then rose by 12.37% to 0.47 in 2022, then rose by 2.0% to 0.48 in 2023, then grew by 7.4% to 0.52 in 2024, then dropped by 0.57% to 0.52 in 2025.
  • Its Asset Utilization Ratio stands at 0.52 for Q4 2025, versus 0.5 for Q3 2025 and 0.51 for Q2 2025.